CDH2 and cholangiocarcinoma: In this study, it was demonstrated that Cslegumain could promote the invasion and migration of cholangiocarcinoma cells through downregulation of E-cadherin and N-cadherin and upregulation of α-actinin 4, β-catenin and iNOS.